» Articles » PMID: 22691499

Analysis of Neural Subtypes Reveals Selective Mitochondrial Dysfunction in Dopaminergic Neurons from Parkin Mutants

Overview
Specialty Science
Date 2012 Jun 14
PMID 22691499
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Studies of the familial Parkinson disease-related proteins PINK1 and Parkin have demonstrated that these factors promote the fragmentation and turnover of mitochondria following treatment of cultured cells with mitochondrial depolarizing agents. Whether PINK1 or Parkin influence mitochondrial quality control under normal physiological conditions in dopaminergic neurons, a principal cell type that degenerates in Parkinson disease, remains unclear. To address this matter, we developed a method to purify and characterize neural subtypes of interest from the adult Drosophila brain. Using this method, we find that dopaminergic neurons from Drosophila parkin mutants accumulate enlarged, depolarized mitochondria, and that genetic perturbations that promote mitochondrial fragmentation and turnover rescue the mitochondrial depolarization and neurodegenerative phenotypes of parkin mutants. In contrast, cholinergic neurons from parkin mutants accumulate enlarged depolarized mitochondria to a lesser extent than dopaminergic neurons, suggesting that a higher rate of mitochondrial damage, or a deficiency in alternative mechanisms to repair or eliminate damaged mitochondria explains the selective vulnerability of dopaminergic neurons in Parkinson disease. Our study validates key tenets of the model that PINK1 and Parkin promote the fragmentation and turnover of depolarized mitochondria in dopaminergic neurons. Moreover, our neural purification method provides a foundation to further explore the pathogenesis of Parkinson disease, and to address other neurobiological questions requiring the analysis of defined neural cell types.

Citing Articles

miR-124 coordinates metabolic regulators acting at early stages of human neurogenesis.

Son G, Na Y, Kim Y, Son J, Clemenson G, Schafer S Commun Biol. 2024; 7(1):1393.

PMID: 39455851 PMC: 11511827. DOI: 10.1038/s42003-024-07089-2.


Longitudinal in vivo metabolic labeling reveals tissue-specific mitochondrial proteome turnover rates and proteins selectively altered by parkin deficiency.

Stauch K, Totusek S, Trease A, Estrella L, Emanuel K, Fangmeier A Sci Rep. 2023; 13(1):11414.

PMID: 37452120 PMC: 10349111. DOI: 10.1038/s41598-023-38484-0.


The compartmentalised nature of neuronal mitophagy: molecular insights and implications.

Borbolis F, Palikaras K Expert Rev Mol Med. 2022; 24:e38.

PMID: 36172898 PMC: 9884780. DOI: 10.1017/erm.2022.31.


Nicotine Has a Therapeutic Window of Effectiveness in a Model of Parkinson's Disease.

Mannett B, Capt B, Pearman K, Buhlman L, VandenBrooks J, Call G Parkinsons Dis. 2022; 2022:9291077.

PMID: 35844833 PMC: 9286976. DOI: 10.1155/2022/9291077.


Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.

Lee S, Park S, Yeo S, Kwon O, Lee M, Yoo H Diagnostics (Basel). 2022; 12(1).

PMID: 35054279 PMC: 8774435. DOI: 10.3390/diagnostics12010112.


References
1.
Sang T, Chang H, Lawless G, Ratnaparkhi A, Mee L, Ackerson L . A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine. J Neurosci. 2007; 27(5):981-92. PMC: 6673194. DOI: 10.1523/JNEUROSCI.4810-06.2007. View

2.
Deng H, Dodson M, Huang H, Guo M . The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A. 2008; 105(38):14503-8. PMC: 2567186. DOI: 10.1073/pnas.0803998105. View

3.
Gegg M, Cooper J, Chau K, Rojo M, Schapira A, Taanman J . Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet. 2010; 19(24):4861-70. PMC: 3583518. DOI: 10.1093/hmg/ddq419. View

4.
Whitworth A, Theodore D, Greene J, Benes H, Wes P, Pallanck L . Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc Natl Acad Sci U S A. 2005; 102(22):8024-9. PMC: 1142368. DOI: 10.1073/pnas.0501078102. View

5.
Wang X, Winter D, Ashrafi G, Schlehe J, Liang Wong Y, Selkoe D . PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell. 2011; 147(4):893-906. PMC: 3261796. DOI: 10.1016/j.cell.2011.10.018. View